Printer Friendly

Skin cancer drugs bring fresh hope.

Byline: Stephen White

A NEW mix of two different drugs can shrink skin cancer tumours by more than 80 per cent, say scientists.

Trials on patients led to a long-lasting reduction in the size of melanoma tumours within 12 weeks of treatment.

The combination of an immunotherapy drug called ipilimumab and the antibody drug nivolumab was reported in the New England Journal of Medicine.

Dr Jeff Wolchok, of New York's Memorial Sloan-Kettering Cancer Centre, said: "This kind of deep and rapid tumour regression has never been seen in melanoma using immunotherapy.

"It suggests that these two drugs could be better used in combination than alone."
COPYRIGHT 2013 Scottish Daily Record & Sunday
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Daily Record (Glasgow, Scotland)
Date:Jun 3, 2013
Previous Article:SMITH: I'M DOWN BUT NOT OUT; Bankrupt ex-Ger upbeat.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters